Join a Legacy of Innovation 110 Years and Counting!Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.SummaryThe Manager, Global Oncology HEOR & RWE will work cross-functionally to implement HEOR and RWE projects for the assigned assets under the direction of a Director or Sr. Director of Global Oncology HEOR & RWE. The person will work with clinical, market access, commercial, regional and medical affairs colleagues to support the clinical development and value creation of the company's oncology assets. Responsibilities include the implementation of outcomes research strategies, health economics research planning, and process improvements to ensure patient access to Daiichi Sankyo's products. This individual will ensure that rigorous HEOR studies are conducted to support the clinical and economic value proposition associated with the Daiichi Sankyo Oncology products. The work involves developing global cost effectiveness and budget impact models and to fill data gaps to support access needs, as well as to design and implement global outcomes research & health economic studies that supports key publications, reimbursement strategies. The person will work closely with other members of the Global Market Access & Pricing department to develop RWE and support market access initiatives aligned to Daiichi Sankyo's products, and represent the department in cross functional working groups and committees from time to time.Responsibilities- HEOR and RWE Deliverables- Support the preparation of global value dossiers which present the product value propositions and the supporting evidence, aligned with the product development strategies and agreed/endorsed by the GPTs, GBTs, Regional HEOR and market access, to realize an optimal value demonstration of the products- Conduct or support HEOR and RWE studies such as early economic models, burden of illness studies, external control arms to support single arm trials, and support the development and analysis of patient-reported outcomes (PRO) instruments in clinical trials- Conduct literature reviews to build payer evidence, economic models, and Global Value Dossiers- Support the analysis of clinical trial data for cost effectiveness models and market specific ad-hoc requests for reimbursement submissions- Conduct RWE studies to support the value story for payers and reimbursement submissions- Support the development of global cost effectiveness and budget impact models for HTA submissions to support reimbursement of indications for Daiichi Sankyo's oncology products- Develop HEOR and RWE communications (e.g. manuscripts, scientific forum presentations, slide decks, symposia), in collaboration with multi-functional teams, to build the peer reviewed published evidence supporting the value propositions for assigned products- Manage vendors in the conduct of HEOR and RWE projects- Evidence Generation Synthesis- Collaborate cross-functionally to gather overview information of target indications including epidemiology, disease burden, unmet needs, cost of illness, and treatment patterns/pathways- Provide and maintain an in-depth understanding of changing Health Technology Assessments, Reimbursement Access environment, payer requirements, and policies of key global markets- Conduct evidence gap assessments in collaboration with global functions and key markets/regions- Stakeholder Engagement- Partner with Regional and Global stakeholders to assess and fill HEOR/RWE evidence gaps- Collaborate with Clinical (RD) to ensure that Payer and reimbursement requirements for key markets are included in the clinical trial / evidence generation plans- Act as an ambassador to drive the access agenda with key stakeholdersQualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.Education Qualifications (from an accredited college or university)- Bachelor's Degree in relevant discipline (e.g., health economics, medicine, pharmacy, public health, epidemiology) requiredExperience Qualifications- 4 or More Years Overall related experience or commensurate education/experience required- 1 or More Years experience in HEOR field (in Healthcare, pharmaceuticals industry, or related) required- Oncology experience, preferably with multi-indication compounds as well as with early-stage compounds- Excellent understanding of the clinical development and life cycle of oncology medicines- Strong knowledge of major markets and their PRA and HTA policies: US and Global (Europe required), both private and government setting- Excellent understanding of HEOR and RWE concepts with hands on experience with HEOR methodologies across all phases of the product life cycle- Track record of successful application of HEOR and RWE with key external stakeholders in major international marketsTravelAbility to travel up to 30% Domestic and Global TravelDaiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.